UNITED STATES FLU VACCINE MARKET IS EXPECTED TO REACH NEARLY US$ 3 BILLION BY 2024.
Growth in US flu vaccine market can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against flu vaccine and the introduction of quadrivalent flu vaccine. Long-term Growth Projection and Development: • Sanofi to Acquire Protein Sciences Corporation • It is likely that more than 185 Million persons being vaccinated with flu vaccines in 2024. • Nearly 160 Million doses of flu vaccines have shipped to US for the 2017-2018 flu season • It is projected that GSK flu vaccine sales value will reach around US$ 1.5 Billion by 2024 • BiondVax reports positive phase 2b clinical trial results for its universal flu vaccine “Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024” provides a deep and thorough evaluation of the United States flu vaccine market. The report provides an in-depth analysis of th...